Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Item
Visit timepoint/Therapeutic regimen timepoint
text
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Code List
Visit timepoint/Therapeutic regimen timepoint
CL Item
Progression - Rezidiv (13)
CL Item
Follow Up - Blatt Nr. 1 (14)
CL Item
Follow Up - Blatt Nr. 2 (15)
CL Item
Follow Up - Blatt Nr. 3 (16)
CL Item
Follow Up - Blatt Nr. 4 (17)
Birth month
Item
Patient date of birth - month
integer
C0421451 (UMLS CUI [1,1])
C2826701 (UMLS CUI [1,2])
Birth year
Item
Patient date of birth - year
integer
C2826771 (UMLS CUI [1])
Consent date
Item
Date of informed consent
date
C2985782 (UMLS CUI [1])
Item
Date of informed consent: status
text
C2985875 (UMLS CUI [1])
Code List
Date of informed consent: status
Item
Gender
text
C0079399 (UMLS CUI [1])
CL Item
maennlich (m)
C0086582 (UMLS CUI-1)
CL Item
weiblich (w)
C0086287 (UMLS CUI-1)
consent tissue specimen
Item
Informed consent for storage of specimen and tissue
boolean
C0021430 (UMLS CUI [1,1])
C1292533 (UMLS CUI [1,2])
Item
Status of disease: de novo AML
text
C1515568 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
Code List
Status of disease: de novo AML
Item
Status of disease: secondary AML
text
C0280449 (UMLS CUI [1])
Code List
Status of disease: secondary AML
CL Item
secondary AML (1)
Leukaemic infiltration
Item
Status of disease: Leukaemic infiltration extramedullary
boolean
C1868812 (UMLS CUI [1])
Item
Status of disease: Disease stage
text
C0699749 (UMLS CUI [1])
Code List
Status of disease: Disease stage
CL Item
First diagnosis (1)
C0205265 (UMLS CUI-1)
C0011900 (UMLS CUI-2)
CL Item
no response (2)
C1704632 (UMLS CUI-1)
C3844738 (UMLS CUI-2)
CL Item
Relapse/Recurrent disease (3)
C0035020 (UMLS CUI-1)
Kommentar Patientendaten
Item
Patient data: Comment
text
C0947611 (UMLS CUI [1])
Bisherige Behandlung AML
Item
Previous antineoplastic protocol
text
C2114510 (UMLS CUI [1])